Short term effect of CRT on biomarkers of cardiac remodelling and fibrosis: NT-proBNP, sST2, galectin-3, and a marker of oxidative stress - ceruloplasmin: A pilot study

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F12%3A43906408" target="_blank" >RIV/00216208:11120/12:43906408 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064173:_____/12:N0000010

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.ijcard.2012.05.053" target="_blank" >http://dx.doi.org/10.1016/j.ijcard.2012.05.053</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.ijcard.2012.05.053" target="_blank" >10.1016/j.ijcard.2012.05.053</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Short term effect of CRT on biomarkers of cardiac remodelling and fibrosis: NT-proBNP, sST2, galectin-3, and a marker of oxidative stress - ceruloplasmin: A pilot study

Popis výsledku v původním jazyce

The objective of the present study was to assess the short-term effect of CRT on biomarkers of cardiac remodelling and fibrosis (sST2, galectin-3, NT-proBNP) together with marker of oxidative stress (ceruloplasmin). Serum levels of soluble ST2, galectin-3, NT-proBNP and ceruloplasmin were measured before and two months after CRT device implantation in 18 consecutive CRT candidates (15 men, 3 women) with device implantation between 1st January and 31st March 2011. Mean patients' age was 68 years, mean LVEF was 29%, 66% of the patients had ischemic aetiology of CHF and 33% had atrial fibrillation. Mean interval between first and second measurement was 66 days.

Název v anglickém jazyce

Short term effect of CRT on biomarkers of cardiac remodelling and fibrosis: NT-proBNP, sST2, galectin-3, and a marker of oxidative stress - ceruloplasmin: A pilot study

Popis výsledku anglicky

The objective of the present study was to assess the short-term effect of CRT on biomarkers of cardiac remodelling and fibrosis (sST2, galectin-3, NT-proBNP) together with marker of oxidative stress (ceruloplasmin). Serum levels of soluble ST2, galectin-3, NT-proBNP and ceruloplasmin were measured before and two months after CRT device implantation in 18 consecutive CRT candidates (15 men, 3 women) with device implantation between 1st January and 31st March 2011. Mean patients' age was 68 years, mean LVEF was 29%, 66% of the patients had ischemic aetiology of CHF and 33% had atrial fibrillation. Mean interval between first and second measurement was 66 days.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

International Journal of Cardiology

ISSN

0167-5273

e-ISSN

—

Svazek periodika

159

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

IE - Irsko

Počet stran výsledku

2

Strana od-do

159-160

Kód UT WoS článku

000307827100026

EID výsledku v databázi Scopus

—